AVD
Next earnings: Jul 30, 2026
Signal
Mixed11
Price
1
Move-5.50%Selling pressure
Volume
1
Volume0.3× avgLight volume
Technical
1
RSIRSI 50Momentum positive
PRICE
Prev Close
2.91
Open
2.85
Day Range2.75 – 2.89
2.75
2.89
52W Range2.05 – 5.92
2.05
5.92
18% of range
VOLUME & SIZE
Avg Volume
348.7K
FUNDAMENTALS
P/E Ratio
-1.7x
Not profitable
EPS (TTM)
Div Yield
0.00%
Beta
0.81
Market-like
Performance
1D
-5.50%
5D
-8.33%
1M
+9.56%
3M
-47.92%
6M
-45.87%
YTD
-28.01%
1Y
-32.93%
Best: 1M (+9.56%)Worst: 3M (-47.92%)
Quick Read
TrendInsufficient MA data
Momentum
NEUTRAL
rev -1% · 29% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 2.3 · FCF negative
Lean Bearish
Key MetricsTTM
Market Cap$78.67M
Revenue TTM$522.88M
Net Income TTM-$45.56M
Free Cash Flow-$40.59M
Gross Margin29.2%
Net Margin-8.7%
Operating Margin1.6%
Return on Equity-21.9%
Return on Assets-6.8%
Debt / Equity1.49
Current Ratio2.32
EPS TTM$-1.59
Alpha SignalsFull Analysis →
What Moves This Stock

Commodity crop prices (corn, soybeans, wheat futures) - higher crop prices drive increased grower spending on crop protection

Weather patterns and planting conditions - drought, excessive rain, or pest pressure affect product demand and application timing

Raw material costs for petroleum-based chemical intermediates - crude oil and natural gas derivatives are key inputs

Generic competition and pricing pressure on off-patent formulations

Macro Sensitivity
Economic Cycle

moderate-to-high - Grower spending on crop inputs correlates with crop commodity prices and farm income, which are cyclical. High-value specialty crops (vegetables, fruits, nuts) are less cyclical than row crops but still sensitive to food demand and export markets. Current negative margins suggest the company is in a down-cycle with compressed farm economics reducing pricing power.

Interest Rates

Rising rates negatively impact AVD through two channels: (1) higher financing costs on the company's debt (Debt/Equity 0.91), pressuring already negative margins, and (2) reduced grower capital spending as farmers face higher equipment and land financing costs. Additionally, higher rates strengthen the USD, which pressures international revenue translation from Latin America and makes US agricultural exports less competitive.

Key Risks

Consolidation among agricultural input suppliers (Bayer-Monsanto, Corteva, Syngenta-ChemChina) creates scale disadvantages for smaller players like AVD in R&D, regulatory costs, and distribution

Shift toward biological crop protection products and integrated pest management reduces demand for synthetic chemical formulations

Regulatory pressure on certain active ingredients (EPA re-registration reviews, state-level restrictions like California DCPA ban) can eliminate product lines

Investor Profile

value/distressed - At 0.3x Price/Sales and 0.7x Price/Book with negative margins, AVD attracts deep value investors betting on operational turnaround or distressed/special situations investors anticipating restructuring. Not suitable for growth, dividend (no dividend capacity with negative cash flow), or quality-focused investors. Requires high risk tolerance and turnaround expertise.

Watch on Earnings
Corn futures (ZCUSX) and soybean futures (ZSUSX) - leading indicators of grower income and crop input spendingCrude oil (CLUSD) and natural gas (NGUSD) prices - key inputs for petroleum-derived chemical intermediatesUSD/BRL exchange rate - impacts Latin American revenue translation and competitivenessGross margin recovery toward 28-32% historical range - critical signal of pricing power or cost control
Health Radar
1 strong1 watch4 concern
25/100
Liquidity
2.32Strong
Leverage
1.49Watch
Coverage
1.1xConcern
ROE
-21.9%Concern
ROIC
1.8%Concern
Cash
$12MConcern
ANALYST COVERAGE12 analysts
BUY
+518.2%upside to target
L $14.00
Med $17.00consensus
H $20.00
Buy
975%
Hold
325%
9 Buy (75%)3 Hold (25%)0 Sell (0%)
Full report →
Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 50 — Bullish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 2.32 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 28.8%

-12.0% vs SMA 50 · -37.3% vs SMA 200

Momentum

RSI50.0
Neutral territory
MACD-0.01
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$5.92+115.3%
EMA 200
$4.02+46.0%
EMA 50
$3.18+15.7%
Current
$2.75
52W Low
$2.05-25.5%
52-Week RangeNear 52-week low
$2.0518th %ile$5.92
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:2
Dist days:0
Edge:+2 acc
Volume Context
Avg Vol (50D)380K
Recent Vol (5D)
202K-47%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 1 analyst
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$585.0M
$585.0M$585.0M
-$0.13
Low1
FY2024
$551.0M
$551.0M$551.0M
-5.8%-$1.08
Low1
FY2025
$536.1M
$536.1M$536.1M
-2.7%-$0.13
Low1
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAVD
Last 8Q
-342.6%avg beat
Beat 1 of 8 quartersMissed 7 Estimates rising
-834%
Q3'24
-590%
Q4'24
-810%
Q2'25
-243%
Q2'25
+73%
Q3'25
-125%
Q4'25
-79%
Q1'26
-133%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
4 Buys/2 SellsNet Buying
Eilers PeterSee Remarks
$32K
Sep 4
SELL
Kaye DouglasCEO
$9K
Jun 11
BUY
Eilers PeterSee Remarks
$16K
Dec 13
SELL
Macicek Steven DDir
$72K
Nov 15
BUY
Rosenbloom Keith MDir
$43K
Sep 4
BUY
Rosenbloom Keith MDir
$149K
Sep 3
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
BlackRock, Inc.
2.1M
2
WELLINGTON MANAGEMENT GROUP LLP
1.7M
3
DIMENSIONAL FUND ADVISORS LP
1.0M
4
TWO SIGMA INVESTMENTS, LP
746K
5
EVR Research LP
720K
6
GEODE CAPITAL MANAGEMENT, LLC
663K
7
STATE STREET CORP
640K
8
Potomac Capital Management, Inc.
622K
News & Activity

AVD News

20 articles · 4h ago

About

american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196

CEO
Eric Wintemute
Nolteanous GilliamSenior Vice President of Manufacturing
Jared StanleySenior Vice President of Supply Chain & Operations
Michael J. DiPaolaSenior Vice President of Strategy, Marketing & R&D
PeersBasic Materials(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
AVD
$2.75-5.50%$79M-588.2%-968.4%1500
$506.11-1.08%$234.1B33.0+297.2%2029.7%1506
$109.06-6.25%$116.4B14.0+1907.6%3206.3%1507
$63.01-4.73%$90.6B33.3+112.4%856.2%1516
$300.10-2.94%$74.0B28.4+206.0%1089.5%1477
$247.62-0.51%$69.7B33.2+215.9%1290.7%1473
$295.38-1.50%$65.8B31.2-52.3%-327.7%1502
Sector avg-3.21%28.8+299.8%1025.2%1497